Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-0.07%||30.24||14.1%||$177.94m|
|HZNP||Horizon Therapeutics Plc||0.00%||91.45||5.5%||$174.64m|
|GWPH||GW Pharmaceuticals Plc||0.00%||218.36||6.1%||$132.57m|
|BHC||Bausch Health Cos., Inc.||-0.07%||30.24||0.0%||$123.31m|
|UTHR||United Therapeutics Corp.||0.00%||202.78||14.1%||$98.97m|
|JAZZ||Jazz Pharmaceuticals Plc||0.00%||166.37||2.3%||$88.00m|
|SAVA||Cassava Sciences, Inc.||0.00%||35.67||0.0%||$69.79m|
|SAGE||SAGE Therapeutics, Inc.||0.00%||75.67||7.6%||$37.98m|
|PRGO||Perrigo Co. Plc||0.07%||40.41||6.9%||$37.14m|
|AMRN||Amarin Corp. Plc||0.00%||5.11||1.5%||$28.81m|
|PCRX||Pacira Biosciences, Inc.||0.00%||69.43||9.9%||$26.96m|
|ICPT||Intercept Pharmaceuticals, Inc.||0.00%||21.41||16.8%||$21.61m|
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.